Zobrazeno 1 - 10
of 71
pro vyhledávání: '"Sydney B. Montesi"'
Autor:
George A. Alba, Iris Y. Zhou, Molly Mascia, Michael Magaletta, Jehan W. Alladina, Francesca L. Giacona, Leo C. Ginns, Peter Caravan, Bradley A. Maron, Sydney B. Montesi
Publikováno v:
Pulmonary Circulation, Vol 14, Iss 1, Pp n/a-n/a (2024)
Abstract Compared to healthy volunteers, participants with post‐acute sequelae of SARS‐CoV‐2 infection (PASC) demonstrated increased plasma levels of the prothrombotic protein NEDD9, which associated inversely with indices of pulmonary vascular
Externí odkaz:
https://doaj.org/article/12422b0881fd4dc08ae772bf641eb802
Autor:
Afshin Ebrahimpour, Manisha Ahir, Min Wang, Anil G. Jegga, Mark D. Bonnen, N. Tony Eissa, Sydney B. Montesi, Ganesh Raghu, Yohannes T. Ghebre
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-12 (2022)
Abstract Idiopathic pulmonary fibrosis (IPF) is a progressive and fatal lung disease of unknown etiology. Currently, pirfenidone and nintedanib are the only FDA-approved drugs for the treatment of IPF and are now the standard of care. This is a signi
Externí odkaz:
https://doaj.org/article/3ce6a0a83e064759a2ff579276fe6229
Autor:
Angela R. Shih, Chayanin Nitiwarangkul, Brent P. Little, Benjamin W. Roop, Sreyankar Nandy, Margit V. Szabari, Nathaniel Mercaldo, Sarah Mercaldo, Sydney B. Montesi, Ashok Muniappan, Sarita R. Berigei, David A. Lynch, Amita Sharma, Lida P. Hariri
Publikováno v:
Respiratory Research, Vol 22, Iss 1, Pp 1-9 (2021)
Abstract Background Accurate diagnosis of idiopathic pulmonary fibrosis (IPF) is essential to inform prognosis and treatment. In 2018, the ATS/ERS/JRS/ALAT and Fleischner Society released new diagnostic guidelines for usual interstitial pneumonitis (
Externí odkaz:
https://doaj.org/article/9cbd7a25eeb64acaa73122d55dbe8257
Publikováno v:
Frontiers in Medicine, Vol 9 (2022)
Externí odkaz:
https://doaj.org/article/8de454ce09324563b7c1b4b21a11d998
Autor:
Sydney B. Montesi, Iris Y. Zhou, Lloyd L. Liang, Subba R. Digumarthy, Sarah Mercaldo, Nathaniel Mercaldo, Ravi T. Seethamraju, Bruce R. Rosen, Peter Caravan
Publikováno v:
ERJ Open Research, Vol 7, Iss 4 (2021)
Introduction Evidence suggests that abnormalities occur in the lung microvasculature in idiopathic pulmonary fibrosis (IPF). We hypothesised that dynamic contrast-enhanced (DCE)-magnetic resonance imaging (MRI) could detect alterations in permeabilit
Externí odkaz:
https://doaj.org/article/0bc0863f48c349579b2077d5b7e5fde0
Autor:
Nantaka Kiranantawat, Shaunagh McDermott, Florian J. Fintelmann, Sydney B. Montesi, Melissa C. Price, Subba R. Digumarthy, Amita Sharma
Publikováno v:
Respiratory Research, Vol 20, Iss 1, Pp 1-8 (2019)
Abstract Background To determine the clinical role, safety, and diagnostic accuracy of percutaneous transthoracic needle biopsy in the evaluation of pulmonary consolidation. Methods A retrospective review of all computed tomography (CT)-guided percut
Externí odkaz:
https://doaj.org/article/221132be49a54097b9de9b4172d80180
Publikováno v:
Journal of Thoracic Disease. 15:1555-1558
Autor:
David Izquierdo-Garcia, Pauline Désogère, Mariane Le Fur, Sergey Shuvaev, Iris Y. Zhou, Ian Ramsay, Michael Lanuti, Onofrio A. Catalano, Ciprian Catana, Peter Caravan, Sydney B. Montesi
Publikováno v:
Journal of Nuclear Medicine. 64:775-781
Autor:
Angela J Frank, Ibiayi Dagogo-Jack, Ioana A Dobre, Sarah Tait, Lana Schumacher, Florian J Fintelmann, Leah M Fingerman, Florence K Keane, Sydney B Montesi
Publikováno v:
The Oncologist. 28:12-22
Patients with interstitial lung disease (ILD), especially those with pulmonary fibrosis, are at increased risk of developing lung cancer. Management of lung cancer in patients with ILD is particularly challenging. Diagnosis can be complicated by diff
Autor:
Dane A, Fisher, Mark C, Murphy, Sydney B, Montesi, Lida P, Hariri, Robert W, Hallowell, Florence K, Keane, Michael, Lanuti, Meghan J, Mooradian, Florian J, Fintelmann
Publikováno v:
Radiologic Clinics of North America. 60:993-1002
Interstitial lung disease (ILD) including idiopathic pulmonary fibrosis increases the risk of developing lung cancer. Diagnosing and staging lung cancer in patients with ILD is challenging and requires careful interpretation of computed tomography (C